Capablanca, Baby Boy .
HRN: 26-94-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/13/2025
11/20/2025
IV
450mg
Q6hours
PCAP-C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes